Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 14:2021:5013529.
doi: 10.1155/2021/5013529. eCollection 2021.

What Is New in Glaucoma: From Treatment to Biological Perspectives

Affiliations
Review

What Is New in Glaucoma: From Treatment to Biological Perspectives

Raffaele Nuzzi et al. J Ophthalmol. .

Abstract

Glaucoma is a chronic silent disease and an irreversible cause of blindness worldwide. Research has made many efforts to improve disease control and especially to anticipate both early diagnosis and treatment of advanced stages of glaucoma. In terms of prevention, networking between professionals and nonprofessionals is an important goal to disseminate information and help diagnose the disease early. On the other hand, the most recent approaches to treat glaucoma outcomes in its advanced stages include electrical stimulation, stem cells, exosomes, extracellular vesicles, and growth factors. Finally, neuronal plasticity-based rehabilitation methods are being studied to reeducate patients in order to stimulate their residual visual capacity. This review provides an overview of new approaches to future possible glaucoma treatment modalities and gives insight into the perspectives available nowadays in this field.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

References

    1. Quigley H. A., Broman A. T. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology. 2006;90(3):262–267. doi: 10.1136/bjo.2005.081224. - DOI - PMC - PubMed
    1. Bourne R. R. A., Stevens G. A., White R. A., et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Global Health. 2013;1(6):e339–e349. doi: 10.1016/S2214-109X(13)70113-X. - DOI - PubMed
    1. Whitson J. T. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opinion on Pharmacotherapy. 2007;8(18):3237–3249. doi: 10.1517/14656566.8.18.3237. - DOI - PubMed
    1. Quigley H. A. Glaucoma. The Lancet. 2011;377(9774):1367–1377. doi: 10.1016/S0140-6736(10)61423-7. - DOI - PubMed
    1. Quaranta L., Riva I., Gerardi C., Oddone F., Floriano I., Konstas A. G. P. Quality of life in glaucoma: a review of the literature. Advances in Therapy. 2016;33(6):959–981. doi: 10.1007/s12325-016-0333-6. - DOI - PMC - PubMed